Antidepressant Drug Interactions and the Cytochrome P450 System
- 1 January 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 29 (Supplement), 10-19
- https://doi.org/10.2165/00003088-199500291-00004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Noninvasive tests of CYP3A enzymesPharmacogenetics, 1994
- A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamineEuropean Journal of Clinical Pharmacology, 1994
- CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humansPharmacogenetics, 1993
- High-Performance Liquid Chromatography Determination of Dextromethorphan and Dextrorphan for Oxidation Phenotyping by Fluorescence and Ultraviolet DetectionTherapeutic Drug Monitoring, 1993
- Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6European Journal of Clinical Pharmacology, 1993
- Effect of Fluvoxamine on the Pharmacokinetics of Imipramine and Desipramine in Healthy SubjectsTherapeutic Drug Monitoring, 1993
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992
- Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).British Journal of Clinical Pharmacology, 1991
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991